CIK 0000849146
- Accelerated filer
- Smaller reporting company
Lifevantage Corp
Sign in to watch- Ticker
- LFVN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 900224471
- Phone
- +1 801-432-9000
- Business address
- 3300 TRIUMPH BLVD, SUITE 700, LEHI, UT, 84043
- Former names
- LIFELINE THERAPEUTICS, INC., YAAK RIVER RESOURCES INC
- 4 Grant or award Director acquired 6,794 shares (grant or award)
- 4 Grant or award Director acquired 6,794 shares (grant or award)
- 4 Grant or award Director acquired 6,794 shares (grant or award)
- 4 Grant or award Director acquired 6,794 shares (grant or award)
- 4 Shares withheld for taxes Chief Operating Officer gave up 752 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Sales &Marketing Officer gave up 864 shares (to pay taxes)
- 4 Shares withheld for taxes General Counsel gave up 672 shares (to pay taxes)
- 4 Shares withheld for taxes CFO and Interim CEO gave up 1,674 shares (to pay taxes)
- 4 Shares withheld for taxes General Counsel gave up 4,230 shares (to pay taxes)
- 4 Open-market sale Chief Sales &Marketing Officer sold 1,250 shares at $13.58 ($16,975)
- 4 Grant or award Chief Operating Officer acquired 3,376 shares (grant or award)
- 4 Grant or award Chief Sales Officer acquired 16,880 shares (grant or award)
- 4 Grant or award CFO and Interim CEO acquired 30,000 shares (grant or award)
- 4 Grant or award Chief Executive Officer acquired 10,303 shares (grant or award)
- 4 Grant or award Chief Operating Officer acquired 4,320 shares (grant or award)
- 4 Grant or award Chief Sales Officer acquired 4,673 shares (grant or award)
- 4 Grant or award General Counsel acquired 4,320 shares (grant or award)
- 4 Grant or award Chief Marketing Officer acquired 3,732 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 15,637 shares (grant or award)
- 4 Open-market sale Chief Sales Officer sold 1,250 shares at $13.26 ($16,575)
Page 14 of 34 · 673 filings